Amit Munshi
CIK 1612551 · President and CEO · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.79M
Companies
8
Total Filings
58
Lifetime Open-Market Net
-$27.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARQT | Director | 9,799 | $24.38 | $238.9K | $0 | 2 | 2026-06-09 |
| IKT | Director | 403,176 | $1.67 | $673.3K | $500.1K | 5 | 2026-02-24 |
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | 4,793 | $28.69 | $137.5K | $0 | 5 | 2025-06-20 |
| ZURA | Director | 777,384 | $3.70 | $2.88M | $0 | 3 | 2025-05-22 |
| Zura Bio Ltd (ZURAW) Delisted | Director | 777,384 | $1.08 | $839.6K | $1000.0K | 3 | 2024-04-24 |
| ARENA PHARMACEUTICALS INC (ARNA) Delisted | President and CEO | 114,647 | $99.99 | $11.46M | -$28.99M | 24 | 2022-03-11 |
| PULM | Director | — | $1.40 | — | $0 | 6 | 2021-02-01 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Chief Executive Officer | 301,841 | — | — | $221.8K | 10 | 2016-03-01 |
Recent Filings · Page 3 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-13 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Buy (P) | +1,000 | $50.4K | EDGAR |
| 2021-08-11 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Buy (P) | +1,000 | $52.9K | EDGAR |
| 2021-03-03 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Grant (A) | +28,800 | $0 | EDGAR |
| 2021-02-01 | PULM | Grant (A) | — | $0 | EDGAR |
| 2021-01-20 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | — | -$6.47M | EDGAR |
| 2021-01-14 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Sell (S) | −14,877 | -$1.12M | EDGAR |
| 2021-01-11 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | +14,877 | -$661.3K | EDGAR |
| 2020-12-09 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Sell (S) | −6,517 | -$456.2K | EDGAR |
| 2020-11-30 | ARENA PHARMACEUTICALS INC (ARNA) Delisted | Mixed | +6,517 | -$339.5K | EDGAR |
| 2020-11-04 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +4,793 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.